AbbVie Inc. is 216.2x more valuable than ANI PHARMACEUTICALS INC by market capitalization ($397.12 B vs $1.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANIP | ABBV |
|---|---|---|
| Market cap | $1.84 B | $397.12 B |
| US-listed rank | #2167 | #30 |
| Revenue (latest FY) | $883.37M | $61.16B |
| Net income (latest FY) | $78.00M | $4.23B |
| Net margin | 8.8% | 6.9% |
| P/E (trailing FY) | 23.5 | 94.0 |
| SEC filings | 1,742 | 1,008 |
AbbVie Inc. is 216.2x more valuable than ANI PHARMACEUTICALS INC by market capitalization ($397.12 B vs $1.84 B).
In their latest fiscal years, ANI PHARMACEUTICALS INC reported $883.37M in revenue while AbbVie Inc. reported $61.16B.
Full pages: ANI PHARMACEUTICALS INC and AbbVie Inc., or browse the full rankings.